Effect of immunoadsorption alone or combined with membrane filtration on hemostasis parameters
Authors:
- 17 August 2020
- journal article
- research article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 35 (5) , 444-452
Abstract
Introduction: ABO‐ or HLA‐incompatible kidney transplantation is possible thanks to pretransplant antibody‐depletion achieved by extracorporeal‐treatment modalities. These methods induce depletion of some plasma proteins and may also impact on proteins involved in hemostasis.Methods: To determine the impact of one session of immunoadsorption (IA) alone or combined with membrane filtration (MF) on clotting factors and natural anticoagulants, we performed a prospective, observational study on 13 patients waiting for HLA‐/ABO‐incompatible kidney transplants. Plasma hemostasis parameters were measured before and immediately after a first session of IA alone in six patients and of IA + MF in seven patients.Results: IA alone induced depletion of fibrinogen and factor XIII (FXIII) whereas IA + MF caused greater depletion of all high‐molecular‐weight hemostatic proteins (fibrinogen, FV, FVIII, FXI, FXIII, von‐Willebrand factor [VWF]). After an IA session, median reductions were 30% for fibrinogen and 43% for FXIII compared to baseline values. After a session of IA + MF, median decreases were 70% for fibrinogen, 54% for FV, 56% for FVIII, 37% for FXI, 78% for FXIII, and 62% for VWF. Noticeably, levels of low‐molecular‐weight factors (<100 kDa) were far less decreased than high‐molecular‐weight proteins with IA + MF, except for protein S and the tissue factor pathway inhibitor, which are known to be partially physiologically bound to high‐molecular‐weight molecules.Conclusions: IA and IA + MF induced significant depletion of some proteins implicated in the hemostatic process; however, IA + MF resulted in stronger modifications to hemostasis parameters than IA alone. This may have potential clinical implications regarding bleeding risk, and particularly depletion of fibrinogen and FXIII.Keywords
This publication has 25 references indexed in Scilit:
- Rare bleeding disorders: diagnosis and treatmentBlood, 2015
- Fibrinogen Reduction and Bleeding Complications in Plasma Exchange, Immunoadsorption and a Combination of the TwoBlood Purification, 2014
- The effect of immunoadsorption with the Immusorba TR‐350 column on coagulation compared to plasma exchangeVox Sanguinis, 2014
- ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorptionTransplant International, 2014
- ABO antibody and complement depletion by immunoadsorption combined with membrane filtration--a randomized, controlled, cross-over trialNephrology Dialysis Transplantation, 2013
- Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapyTransfusion, 2013
- Differences in Reduction of Coagulation Factor XIII (F13) Between Immunoadsorption Plasmapheresis and Double Filtration PlasmapheresisTherapeutic Apheresis and Dialysis, 2012
- Tissue factor pathway inhibitor: structure-functionFrontiers in Bioscience-Landmark, 2012
- Desensitization in HLA-Incompatible Kidney Recipients and SurvivalNew England Journal of Medicine, 2011
- High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein.Proceedings of the National Academy of Sciences, 1981